Smartleaf Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Smartleaf Asset Management’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.56K	Buy	+77	New	+$3.91K	﹤0.01%	2745

Other funds holding ETON

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

National Philanthropic Trust Jenkintown, Pennsylvania $7.05B AUM 11.49% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Smartleaf Asset Management's ETON Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Eton Pharmaceutcials (ETON) in Q3 2026: 77 shares worth $4.56K. The stake represents ﹤0.01% of the portfolio and ranks #2745 among its holdings.

162 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

Smartleaf Asset Management held 77 shares of Eton Pharmaceutcials worth $4.56K as of Q3 2026.
Eton Pharmaceutcials was a new Smartleaf Asset Management position in Q3 2026.
Eton Pharmaceutcials made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2745 holding.
162 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.